# Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Clinical trial · University Hospital Birmingham

- Archive id: nct:NCT00553124
- Published: 2007-11-05
- Venue: ClinicalTrials.gov
- ClinicalTrials.gov: https://clinicaltrials.gov/study/NCT00553124
- Source URL: https://clinicaltrials.gov/study/NCT00553124
- Provenance: clinicaltrials

## Abstract

RATIONALE: Studying different factors that effect patients with newly diagnosed bladder cancer may help doctors learn more about the disease, improve the ability to plan cancer treatment, and help patients live more comfortably. PURPOSE: This clinical trial is studying different factors affecting patients with newly diagnosed bladder cancer.

_Abstract reproduced under ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters._

## Trial details

- status: UNKNOWN
- phase: PHASE3
- study type: INTERVENTIONAL
- enrollment: 3400
- sponsor: University Hospital Birmingham
- conditions: Bladder Cancer
- interventions: DRUG: selenium; DRUG: vitamin E; PROCEDURE: biopsy; PROCEDURE: chemoprevention; PROCEDURE: cryopreservation; PROCEDURE: cytology specimen collection procedure; PROCEDURE: diagnostic procedure; PROCEDURE: gene expression analysis; PROCEDURE: immunohistochemistry staining method; PROCEDURE: laboratory biomarker analysis
- start date: 2005-12-01
- has results: false
- data source: ClinicalTrials.gov
- data processed: 2026-10-29T09:00:05
- modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters

Topics: [Gene & Cell Therapy](https://space-kitty.com/topics/gene-cell-therapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.